Skip to main content
Advertisement
Live broadcast

Russia has launched the production of ten previously unreleased medicines

0
Photo: IZVESTIA/Sergey Lantyukhov
Озвучить текст
Select important
On
Off

In Russia, in the first half of 2026, 10 drugs from the list of vital and essential drugs that had not been produced in the country before were registered and put into production, the Ministry of Health said. They are used for the treatment of cancer, epilepsy, multiple sclerosis and rheumatoid arthritis, as well as for intravenous nutrition and MRI diagnostics.

According to the Ministry, the production of these drugs will strengthen the country's technological sovereignty, reduce dependence on foreign supplies and ensure their availability at a lower price. At the same time, the list of the latest treatment methods available under compulsory medical insurance is expanding.

"This year, new technologies were included in the state guarantee program, which received registration and permission for use in 2025-2026. So, in 2026, CAR-T therapy and personalized cancer vaccines, including those using mRNA technology, were included in the state guarantee program," said Mikhail Murashko, Minister of Health.

From the beginning of 2025 to the second quarter of 2026, more than 1.5 thousand medical devices were also registered in Russia. Among them are the first domestic hemodialysis machine, a surgical robotic endoscopic complex and an intraocular lens with continuous focus. In total, more than 50 scientific studies are planned under the national project. According to their results, it is expected to develop at least 10 medicines, over 30 medical devices and 10 innovative medical technologies. By 2030, it is also planned to develop 25 gene therapy drugs and personalized cellular products. The national project "New Technologies for saving Health" is aimed at supporting such research.

According to the minister, the key task is to increase the duration of an active and healthy human life. In turn, scientific and technological development is one of the tools for achieving national goals.

Pharmaceutical production facilities are being set up in the regions to produce the latest drugs. So. Russia's largest production facility for peritoneal dialysis solutions will be built in the Perm Special Economic Zone. This method allows patients with renal insufficiency to undergo the procedure at home. Investments in the project will exceed 5 billion rubles, and the launch is planned before the end of 2030. And already in the Tomsk region, it is planned to create a full-cycle production of blood plasma preparations with a capacity of about 300 thousand liters of plasma per year. The volume of investments is estimated at 4.5 billion rubles, 250 jobs will be created.

Thus, scientific research in the field of medicine is being dynamically introduced into real production. But the key task is to create a full cycle of implementation of developments: from scientific ideas to use in the clinic. "It is important that our developments, which are created within the framework of government assignments, really get a faster start and accelerated implementation in practical medicine," said Deputy Minister of Health Sergey Glagolev.

An example of such a solution is a portable digital colposcope developed by scientists from Samara State Medical University of the Russian Ministry of Health (SamSMU), which has already been admitted to the cancer clinic of Tolyatti City Clinical Hospital No. 5, and is being tested in eight medical institutions in the region. The device was developed as part of a large-scale pilot project using artificial intelligence (AI) technologies for colpogram analysis, which was attended by the Almazov National Research Medical Center. It is intended for early detection of cervical pathologies and will be used in oncological screening.

The national project "New Health Saving Technologies" is aimed at developing advanced scientific and technological solutions in medicine. It is designed to ensure the technological sovereignty of the country, increase the accessibility of innovative developments for patients and create conditions for strengthening domestic medical science.

Переведено сервисом «Яндекс Переводчик»

Live broadcast